DK2672950T3 - Anti-inflammatorisk effekt af mikrofibrilleret cellulose - Google Patents

Anti-inflammatorisk effekt af mikrofibrilleret cellulose Download PDF

Info

Publication number
DK2672950T3
DK2672950T3 DK12716475.4T DK12716475T DK2672950T3 DK 2672950 T3 DK2672950 T3 DK 2672950T3 DK 12716475 T DK12716475 T DK 12716475T DK 2672950 T3 DK2672950 T3 DK 2672950T3
Authority
DK
Denmark
Prior art keywords
microfibrillated cellulose
cellulose
skin
mfc
aqueous
Prior art date
Application number
DK12716475.4T
Other languages
English (en)
Inventor
Kaisa Herranen
Mia Lohman
Original Assignee
Upm Kymmene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43629806&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2672950(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Upm Kymmene Corp filed Critical Upm Kymmene Corp
Application granted granted Critical
Publication of DK2672950T3 publication Critical patent/DK2672950T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polymers & Plastics (AREA)

Claims (8)

1. Mikrofibrilleret cellulose til anvendelse ved en fremgangsmåde til behandling af hudinflammation.
2. Mikrofibrilleret cellulose til anvendelse ved en fremgangsmåde til behandling af hudinflammation ifølge krav 1, hvor den mikrofibrillerede cellulose er indeholdt i en salve, et serum, en vandig gel, en skum, en creme, en emulsion af vandig og fedtet fase, en lotion eller en pasta.
3. Mikrofibrilleret cellulose til anvendelse ved en fremgangsmåde til forebyggelse af inflammationsinduceret keratinocyt-de-differentiering.
4. Mikrofibrilleret cellulose til anvendelse ved fremgangsmåden til behandling af hudinflammationinduceret keratinocyt-de-differentiering ifølge krav 3, hvor den mikrofibrillerede cellulose er indeholdt i en salve, et serum, en vandig gel, en skum, en creme, en emulsion af vandig og fedtet fase, en lotion eller en pasta.
5. Mikrofibrilleret cellulose til anvendelse ved en fremgangsmåde til behandling af atopisk dermatitis.
6. Mikrofibrilleret cellulose til anvendelse ved fremgangsmåden til behandling af atopisk hudinflammation ifølge krav 5, hvor den mikrofibrillerede cellulose er indeholdt i en salve, et serum, en vandig gel, en skum, en creme, en emulsion af vandig og fedtet fase, en lotion eller en pasta.
7. Mikrofibrilleret cellulose til anvendelse ved en fremgangsmåde til behandling af psoriasis.
8. Mikrofibrilleret cellulose til anvendelse ved fremgangsmåden til behandling af psoriasis ifølge krav 7, hvor den mikrofibrillerede cellulose er indeholdt i en salve, et serum, en vandig gel, en skum, en creme, en emulsion af vandig og fedtet fase, en lotion eller en pasta.
DK12716475.4T 2011-02-11 2012-02-10 Anti-inflammatorisk effekt af mikrofibrilleret cellulose DK2672950T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20115135A FI126259B (fi) 2011-02-11 2011-02-11 Mikrofibrilloitu selluloosa käytettäväksi erityisesti atooppisen ihotulehduksen ja psoriasiksen hoidossa
PCT/FI2012/050129 WO2012107648A1 (en) 2011-02-11 2012-02-10 Anti-inflammatory effect of microfibrillated cellulose

Publications (1)

Publication Number Publication Date
DK2672950T3 true DK2672950T3 (da) 2018-02-12

Family

ID=43629806

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12716475.4T DK2672950T3 (da) 2011-02-11 2012-02-10 Anti-inflammatorisk effekt af mikrofibrilleret cellulose

Country Status (8)

Country Link
US (1) US9018189B2 (da)
EP (1) EP2672950B1 (da)
JP (1) JP6386226B2 (da)
DK (1) DK2672950T3 (da)
ES (1) ES2661582T3 (da)
FI (1) FI126259B (da)
NO (1) NO2672950T3 (da)
WO (1) WO2012107648A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI126513B (fi) * 2011-01-20 2017-01-13 Upm Kymmene Corp Menetelmä lujuuden ja retention parantamiseksi ja paperituote
US9370478B2 (en) 2012-11-09 2016-06-21 Johnson & Johnson Consumer Inc. Skin care compositions containing cotton and citrus-derived materials
US20140134217A1 (en) 2012-11-09 2014-05-15 Johnson & Johnson Consumer Companies, Inc. Leave-on compositions containing cellulose materials
US20140134218A1 (en) 2012-11-09 2014-05-15 Johnson & Johnson Consumer Companies, Inc. Rinse-off skin care compositions containing cellulosic materials
FI126109B (en) 2013-02-22 2016-06-30 Upm Kymmene Corp Nanofibril polysaccharide for use in the control and prevention of constriction and scarring
FR3016296B1 (fr) * 2014-01-14 2021-06-25 Feeligreen Dispositif pour l'electrostimulation et/ou l'iontophorese
FI129421B (fi) 2014-03-12 2022-02-15 Maelkki Yrjoe Nanoselluloosan ja sen esiasteiden valmistus ja käyttö
FI125758B (en) 2014-12-22 2016-02-15 Upm Kymmene Corp A method for reducing the viscosity of nanofibrillar cellulose hydrogel
FI129934B (en) 2015-02-13 2022-11-15 Upm Kymmene Corp Sewing thread, method of making sewing thread and its use
EP3228329B1 (en) * 2016-04-06 2022-06-08 UPM-Kymmene Corporation A method for preparing a medical product comprising nanofibrillar cellulose and a medical product
WO2018064284A1 (en) 2016-09-30 2018-04-05 Novaflux, Inc. Compositions for cleaning and decontamination
EP3833362A4 (en) * 2018-08-06 2022-05-18 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd CELLULOSE-BASED TOPICAL FORMULATIONS
CA3156824A1 (en) 2019-10-03 2021-04-08 Novaflux Inc. Oral cavity cleaning composition, method, and apparatus

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4378381A (en) 1980-10-31 1983-03-29 International Telephone And Telegraph Corporation Suspensions containing microfibrillated cellulose
JPS6239507A (ja) * 1985-08-13 1987-02-20 Daicel Chem Ind Ltd 皮膚手入れ用化粧料
DE4328871A1 (de) 1993-08-27 1995-03-02 Beiersdorf Ag Mittel gegen empfindliche, hyperreaktive Hautzustände, atopische Dermatiden, Pruritus, Psoriasis Prurigo, Photodermatosen und Ichthyosis
FR2730252B1 (fr) 1995-02-08 1997-04-18 Generale Sucriere Sa Cellulose microfibrillee et son procede d'obtention a partir de pulpe de vegetaux a parois primaires, notamment a partir de pulpe de betteraves sucrieres.
FR2744632B1 (fr) 1996-02-13 1998-03-27 Oreal Utilisation d'une suspension aqueuse de microfibrilles d'origine naturelle pour la preparation de compositions cosmetiques ou dermatologiques, compositions cosmetiques ou dermatologiques et applications
JPH09275424A (ja) 1996-04-04 1997-10-21 Matsushita Electric Ind Co Ltd 送信装置
ATE199924T1 (de) 1996-07-15 2001-04-15 Rhodia Chimie Sa Zusammensetzung enthaltend nanofibrillen von cellulose und carboxylierte cellulose mit niedriegem substitutionsgrad
FR2769836B1 (fr) 1997-10-21 2000-03-10 Rhodia Chimie Sa Utilisation de nanofibrilles de cellulose essentiellement amorphes associees a au moins un compose organique polyhydroxyle dans des formulations cosmetiques
FR2822679A1 (fr) 2001-03-30 2002-10-04 Oreal Composition cosmetique comprenant un melange de fibres
JP4961772B2 (ja) * 2005-03-01 2012-06-27 Ｊｎｃ株式会社 硫酸化セルロース及びその塩から選ばれた化合物並びに皮膚炎治療剤
WO2007027849A2 (en) 2005-08-31 2007-03-08 Board Of Regents, The University Of Texas System Multiribbon nanocellulose as a matrix for wound healing
JP5600005B2 (ja) 2007-09-05 2014-10-01 太陽化学株式会社 水溶性電界紡糸シート
US8410125B2 (en) * 2007-11-05 2013-04-02 Yagna Limited Sulfonated precursors of thymidine for the treatment of epithelial hyperplasias

Also Published As

Publication number Publication date
NO2672950T3 (da) 2018-05-12
US9018189B2 (en) 2015-04-28
JP2014505093A (ja) 2014-02-27
EP2672950A1 (en) 2013-12-18
ES2661582T3 (es) 2018-04-02
FI126259B (fi) 2016-09-15
EP2672950B1 (en) 2017-12-13
FI20115135A (fi) 2012-08-12
FI20115135L (fi) 2012-08-12
WO2012107648A1 (en) 2012-08-16
JP6386226B2 (ja) 2018-09-05
US20140045785A1 (en) 2014-02-13
FI20115135A0 (fi) 2011-02-11

Similar Documents

Publication Publication Date Title
DK2672950T3 (da) Anti-inflammatorisk effekt af mikrofibrilleret cellulose
Tracy et al. Extracellular matrix and dermal fibroblast function in the healing wound
Farwick et al. Fifty-kDa hyaluronic acid upregulates some epidermal genes without changing TNF-α expression in reconstituted epidermis
US11224566B2 (en) Composition comprising a crosslinked hyaluronic acid (HA) in combination with a low-molecular HA and/or an agent stimulating endogenous HA synthesis
US9675628B2 (en) Method for producing a mixture of neutral oligosaccharides extracted from flaxseed
WO2009106934A1 (en) Angico-branco (piptadenia colubrina) extracts for use in cosmetic and dermatological formulations
KR102582633B1 (ko) 상피세포 성장인자 리포좀 및 성장인자 복합물이 함유된 피부 재생 및 주름 개선용 화장료 조성물
Wong et al. Silk for pharmaceutical and cosmeceutical applications
FR3020950A1 (fr) Extrait de plante marine pour la cicatrisation des plaies
WO2020065213A1 (fr) Utilisation d'un extrait d'agave pour renforcer la fonction barrière de la peau, du cuir chevelu et/ou des muqueuses et moduler le microbiote cutané
JP2021500393A (ja) 植物ゾウゲ抽出物（ファイテレファス属種（Ｐｈｙｔｅｌｅｐｈａｓ ｓｐ．））の化粧的使用
US10959934B2 (en) Micro- or nanoparticular vesicles comprising crosslinked hyaluronic acid, compositions comprising the same and method for their use in skin care
EP3687632B1 (fr) Utilisation cosmetique de cellules meristematiques de syringa vulgaris l. pour une action anti-age sur la peau
FR2960436A1 (fr) Composition cosmetique - dermatologique comprenant au moins une huile essentielle et leur utilisation
FR3106057A1 (fr) Composition cosmétique comprenant des extraits de Padina Pavonica pour améliorer cicatrisation de la peau
US20190314649A1 (en) Micro- or nanoparticular multilamellar vesicles, compositions comprising the same and method for their use in skin care
WO2024009041A1 (fr) Un extrait de cellules meristematiques d'otanthus maritimus et ses utilisations, notamment cosmetiques
FR3137583A1 (fr) Un extrait de cellules meristematiques d’otanthus maritimus et ses utilisations, notamment cosmetiques
FR3019043A1 (fr) Utilisation cosmetique d'un extrait de crambe maritima
WO2023088980A1 (fr) Composition cosmetique comprenant de la sève de boulot, de la sève d'érable, de l'extrait de feuilles de saule et de l'extrait de feuilles de ginkgo biloba
CH715793B1 (de) Dermokosmetische Zusammensetzung, die plättchenähnliche Synthesemoleküle zur Behandlung von Zeichen der Hautalterung enthält.
WO2020008117A1 (fr) Utilisation cosmetique de hrgp (hydroxyprolin rich glycoproteins) issues de cellules d'ajuga reptans pour prevenir et/ou lutter contre les effets du vieillissement de la peau
FR3071410A1 (fr) Utilisation cosmetique de cellules meristematiques de syringa vulgaris l. pour une uniformisation du teint
AUGUSTINE et al. CUTANEOUS WOUND CARE: GRAFTS TO TISSUE-ENGINEERED SKIN SUBSTITUTES
FR2932381A1 (fr) Composition cosmetique ou pharmaceutique contenant une association de hyaluronane reticule ou non reticule et d'heparine et/ou un ou plusieurs derives heparinoides pour voie topique et injectable